Parkinson's disease or multiple system atrophy: potential separation by quantitative susceptibility mapping.

Franz MarxreiterVera LambrechtAngelika MenneckeJannis HanspachJelena JukicMartin RegensburgerJuergen HerrlerAlexander GermanJan KassubekGeorg GrönHans-Peter MüllerFrederik B LaunArnd DörflerJuergen WinklerManuel A Schmidt

Published in: Therapeutic advances in neurological disorders (2023)

Putaminal susceptibility measures, in particular on ultra-high-field MRI, may distinguish MSA patients from both, PD and controls, allowing an early and sensitive diagnosis of MSA.

Keyphrases

high resolution
end stage renal disease
ejection fraction
magnetic resonance imaging
newly diagnosed
chronic kidney disease
computed tomography
contrast enhanced
patient reported outcomes
climate change
risk assessment
liquid chromatography